Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Color Blindness, Red in Switzerland
Total 0 results
Nothing found
Sponsors and Collaborators
Shanghai GeneChem Co., Ltd.
Ministry of Public Health, Cameroon
Hungarian Dental Association
Cogniciti
Smart Meter Corporation
Vivid Pharma Inc.
UNITI Consortium
Huisartspraktijk Handellaan
Salena Killion
Nutrabolt
NERv Technology Inc
Université de Genève (UNIGE)
Zhongda Hospital, Medical School, Southeast University
Defence Services Medical Academy (DSMA), Myanmar
Impulse Dynamics, Inc.
Health Information Technology Solutions (HITS) LLC
Pia Jaeger, MD, PhD
BioNova Pharmaceuticals (Shanghai) LTD.
HBSA
The Affiliated Hospital of Xuzhou Medical University
View Full List
Medical Conditions
Cerebral Arterial Disease
Radiofrequency Ablation Treatment
Advanced Bladder Carcinoma
VEXAS Syndrome
Vertebral Compression Fractures in Osteoporotic Patients
Alzheimer Disease Focal
Biomarkers, Pharmacological
Research Mentoring Skills
Old Age (Focus; Not a Recognized Condition)
PPA Syndrome
Immediate Implant Placement
PET-CT Specimen Imager
SMA - Spinal Muscular Atrophy
Eye Disease, Hereditary
Premature Rupture of Membranes Prolonged
Failed Induction
Pain, Breakthrough
Infection, Bacterial
Cardiovascular Primary Prevention
Endoleaks
View Full List
Drug Interventions
Microneedling with topical glycolic acid 35%.
CJ-12420 200mg + Clarithromycin 500mg
80% oxygen
TQB2450
Rosuvastatin
OXP005
18F-FDG
Oxymorphone hydrochloride (HCl)
INT-747
Phase B: Triplixam / Elestar HCT
Durvalumab + chemotherapy treatment
Cefadroxil until drain removal
20 mg/kg IV FL-301
HPN328
Acetylsalicylic acid
CNTO 6785 50 mg
5 FU continuous
Olopatadine hydrochloride 0.2%
Lacosamide
0.75% Ropivacaine
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Costa Rica
Contract Research Organizations in Dominican Republic
Contract Research Organizations in El Salvador
Contract Research Organizations in Germany
Contract Research Organizations in Jordan
Contract Research Organizations in Mauritius
Contract Research Organizations in Netherlands
Contract Research Organizations in Pakistan
Contract Research Organizations in Panama
Contract Research Organizations in Paraguay
Contract Research Organizations in Peru
Contract Research Organizations in Portugal
CRO list by country
CROs in Mauritania
SGS
All CROs in Mauritania
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe